Bristol Myers Squibb has released new 5-year results from the long-term trial evaluating Sotyktu for the treatment of adults ...

Significant clinical improvements seen with and without induction therapy, with faster initial response with induction.

Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of living with the autoimmune skin condition, Goedert is spreading awareness ...

“The initiation of the Phase 1b trial in subjects with moderate-to-severe plaque psoriasis represents a major step forward in advancing our novel and highly selective oral BET ...

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind ...

The development of the aqueous cream formulation of CAL/BDP, approved for plaque psoriasis in 2020, was a “big deal” because until then, the pH incompatibility of the two active ingredients ...

With this approval, Celltrion will begin a global phase 3 clinical trial for CT-P55, a biosimilar of Cosentyx, involving 375 patients with plaque psoriasis. A comparative study will be conducted ...

2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and ...

Last Sunday was Palmar’s last service at Julia & Henry’s and most certainly its last service ever. After a rollercoaster eight years the time has come to close it and move on," owner Javier ...